Neutrophil extracellular traps contribute to tissue plasminogen activator resistance in acute ischemic stroke. Issue 9 (27th August 2021)

• Record Type: Journal Article
• Authors: Zhang, Shuoqi; Cao, Yuze; Du, Jingwen; Liu, Huan; Chen, Xiaojing; Li, Mengdi; Xiang, Mengqi; Wang, Chengyue; Wu, Xiaoming; Liu, Langjiao; Wang, Chunli; Wu, Yinsong; Li, Zhuxin; Fang, Shaohong; Shi, Jialan; Wang, Lihua
• Is Part Of: FASEB journal. Volume 35:Issue 9(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-08-27
• Subjects: endothelial cells -- hypercoagulable state -- neutrophil extracellular traps -- platelets -- stroke -- thrombolysis resistance; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.202100471RR
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract: Circulating neutrophil extracellular traps (NETs) resistant to t‐PA have not been studied completely although NETs in thrombi may contribute to tissue plasminogen activator (t‐PA) resistance. This research intended to elucidate whether circulating NETs are associated with t‐PA resistance and the underlying mechanism. The levels of NETs were detected in the circulating neutrophils, ischemic brain tissue of acute ischemic stroke (AIS) patients, and transient middle cerebral artery occlusion (tMCAO) models. NET formation in blood, thrombi, and ischemic brain tissue of mice were analyzed by immunofluorescence. Exposed phosphatidylserine (PS) was assessed using flow cytometry and confocal microscopy. Procoagulant activity (PCA) was evaluated using fibrin formation assays, thrombin, and purified coagulation complex. The plasma levels of NETs in AIS patients were significantly higher than those in healthy individuals. After thrombolysis, a significant increase was noted in NET markers in no‐improvement patients, while the changes in improvement patients were not significant. Importantly, NETs were decorated with von Willebrand factor (vWF) and plasminogen activator inhibitor‐1 (PAI‐1) in the blood and thrombi, which could reverse the fibrinolytic effects. In addition, NETs activated platelets (PLTs) and endothelial cells (ECs), stimulating a procoagulant phenotype and facilitating vWF and PAI‐1 release. DNase I, activated protein C (APC), and sivelestat markedly inhibited these effects. Furthermore, targeting NETs protected mice from tMCAO‐induced cerebral ischemia, possibly by regulating vWF and PAI‐1. In summary, NETs may contribute to t‐PA resistance in AIS through activation of PLTs and ECs. Strategies against NETs may present a promising therapeutic approach to improve the thrombolysis efficiency of t‐PA in AIS patients.